Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria

Kinase inhibitors comprise a diverse cohort of chemical scaffolds that are active in multiple biological systems. Currently, thousands of eukaryotic kinase inhibitors are commercially available, have well-characterized targets, and often carry pharmaceutically favorable toxicity profiles. Recently,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ACS Infect Dis
Autori principali: Barker, William T., Nemeth, Ansley M., Brackett, Sara M., Basak, Akash K., Chandler, Courtney E., Jania, Leigh A., Zuercher, William J., Melander, Roberta J., Koller, Beverly H., Ernst, Robert K., Melander, Christian
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944324/
https://ncbi.nlm.nih.gov/pubmed/31434474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.9b00212
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi